Nomura Holdings ADR Earnings Calls
| Release date | Oct 28, 2025 |
| EPS estimate | $0.170 |
| EPS actual | $0.220 |
| EPS Surprise | 29.41% |
| Revenue estimate | 2.989B |
| Revenue actual | 3.393B |
| Revenue Surprise | 13.50% |
| Release date | Jul 29, 2025 |
| EPS estimate | $0.250 |
| EPS actual | $0.240 |
| EPS Surprise | -4.00% |
| Revenue estimate | 3.081B |
| Revenue actual | 7.987B |
| Revenue Surprise | 159.20% |
| Release date | Jun 23, 2025 |
| EPS estimate | - |
| EPS actual | $0.161 |
| Revenue estimate | - |
| Revenue actual | 6.751B |
| Release date | Jan 29, 2025 |
| EPS estimate | $0.140 |
| EPS actual | - |
| Revenue estimate | 3.036B |
| Revenue actual | - |
Last 4 Quarters for Nomura Holdings ADR
Below you can see how NMR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jan 29, 2025 |
| Price on release | $6.41 |
| EPS estimate | $0.140 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jan 23, 2025 | $6.15 |
| Jan 24, 2025 | $6.26 |
| Jan 27, 2025 | $6.29 |
| Jan 28, 2025 | $6.37 |
| Jan 29, 2025 | $6.41 |
| Jan 30, 2025 | $6.45 |
| Jan 31, 2025 | $6.48 |
| Feb 03, 2025 | $6.45 |
| Feb 04, 2025 | $6.46 |
| 4 days before | 4.23% |
| 4 days after | 0.780% |
| On release day | 0.624% |
| Change in period | 5.04% |
| Release date | Jun 23, 2025 |
| Price on release | $6.14 |
| EPS estimate | - |
| EPS actual | $0.161 |
| Date | Price |
|---|---|
| Jun 16, 2025 | $6.19 |
| Jun 17, 2025 | $6.10 |
| Jun 18, 2025 | $6.26 |
| Jun 20, 2025 | $6.16 |
| Jun 23, 2025 | $6.14 |
| Jun 24, 2025 | $6.25 |
| Jun 25, 2025 | $6.21 |
| Jun 26, 2025 | $6.32 |
| Jun 27, 2025 | $6.60 |
| 4 days before | -0.81% |
| 4 days after | 7.49% |
| On release day | 1.79% |
| Change in period | 6.62% |
| Release date | Jul 29, 2025 |
| Price on release | $6.99 |
| EPS estimate | $0.250 |
| EPS actual | $0.240 |
| EPS surprise | -4.00% |
| Date | Price |
|---|---|
| Jul 23, 2025 | $6.87 |
| Jul 24, 2025 | $6.75 |
| Jul 25, 2025 | $6.79 |
| Jul 28, 2025 | $6.68 |
| Jul 29, 2025 | $6.99 |
| Jul 30, 2025 | $6.73 |
| Jul 31, 2025 | $6.65 |
| Aug 01, 2025 | $6.68 |
| Aug 04, 2025 | $6.76 |
| 4 days before | 1.75% |
| 4 days after | -3.29% |
| On release day | -3.72% |
| Change in period | -1.60% |
| Release date | Oct 28, 2025 |
| Price on release | $7.21 |
| EPS estimate | $0.170 |
| EPS actual | $0.220 |
| EPS surprise | 29.41% |
| Date | Price |
|---|---|
| Oct 22, 2025 | $7.00 |
| Oct 23, 2025 | $6.96 |
| Oct 24, 2025 | $6.92 |
| Oct 27, 2025 | $7.08 |
| Oct 28, 2025 | $7.21 |
| Oct 29, 2025 | $7.07 |
| Oct 30, 2025 | $7.06 |
| Oct 31, 2025 | $7.12 |
| Nov 03, 2025 | $7.14 |
| 4 days before | 3.00% |
| 4 days after | -0.97% |
| On release day | -1.94% |
| Change in period | 2.00% |
Nomura Holdings ADR Earnings Call Transcript Summary of Q4 2025
Nomura reported a strong fiscal 2025 with group net revenue up 21% y/y to ¥1,892.5bn and record net income of ¥340.7bn (EPS ¥111.03), driven by broad-based strength across Wealth Management, Investment Management and Wholesale. Recurring revenue in Wealth Management rose 30% and Investment Management business revenue grew 20%; AUM reached ¥89.3tn (exceeding the FY KPI) with eight consecutive quarters of net inflows. Wholesale delivered gains across regions and businesses despite a softer Q4, and global international income before tax reached a post-2003 high. Capital returns: a year-end dividend of ¥34 (total annual ¥57 including the ¥10 commemorative dividend) and a share buyback program of up to 100m shares / ¥60bn (May–Dec) to improve capital efficiency and satisfy stock-based compensation needs. CET1 was 14.5% at March-end after Basel III finalization; management targets CET1 comfortably above their medium-term target of 11%. Q4 topline and income softened q/q (Q4 net revenue ¥452.7bn, income before tax ¥97.7bn) amid yen strength and equity market weakness, and management emphasized disciplined risk and cost control, ongoing transformation initiatives, and a cautious outlook given market volatility. Strategic moves include establishing a banking division and agreeing to acquire Macquarie’s US & European public asset management business to scale and globalize Investment Management.
Sign In
Buy NMR